Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic Cancer

NCT03825289 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03825289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03825289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic Cancer
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Terminated
Start date
January 30, 2019
Completion date
August 3, 2025
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic carcinoma, stage ii pancreatic cancer, stage iia pancreatic cancer, stage iib pancreatic cancer, stage iii pancreatic cancer, stage iv pancreatic cancer, unresectable pancreatic carcinoma